ZEN Graphene Solutions Ltd (ZEN : TSX-V)
Common Stock
$0.95
CAD
+0.17 (21.79%)
Last updated: 2026-07-31
Get ZEN alerts:
ZEN
ZEN Graphene Solutions Ltd
WealthAwesomePerformance
1 Day
+21.79%
1 Week
+28.38%
1 Month
+46.15%
YTD
+2.15%
Key Statistics
Market Cap
$120.29M
52W High
$1.70
52W Low
$0.52
P/E Ratio
-
50 Day MA
$0.70
200 Day MA
$0.89
Beta
0.29
Dividend Yield
-
Advertisement
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/31/2026 | $0.79 | $0.95 | $0.78 | $0.95 | $0.95 | 260,165 |
| 7/30/2026 | $0.77 | $0.80 | $0.77 | $0.78 | $0.78 | 66,243 |
| 7/29/2026 | $0.80 | $0.83 | $0.76 | $0.78 | $0.78 | 236,365 |
| 7/28/2026 | $0.84 | $0.84 | $0.78 | $0.78 | $0.78 | 100,715 |
| 7/27/2026 | $0.78 | $0.83 | $0.78 | $0.81 | $0.81 | 148,894 |
| 7/24/2026 | $0.77 | $0.79 | $0.74 | $0.74 | $0.74 | 182,486 |
| 7/23/2026 | $0.76 | $0.78 | $0.72 | $0.78 | $0.78 | 262,344 |
| 7/22/2026 | $0.74 | $0.80 | $0.73 | $0.78 | $0.78 | 379,758 |
| 7/21/2026 | $0.66 | $0.75 | $0.64 | $0.71 | $0.71 | 329,710 |
| 7/20/2026 | $0.65 | $0.68 | $0.64 | $0.64 | $0.64 | 123,075 |
Analyst Price Targets
Based on analyst covering ZEN
Wall Street analysts forecast ZEN stock price to rise 215.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$3.00
+215.8% Upside
Current Price
C$0.95
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ZEN's historical volatility
30-Day Vol
121.7%
Annualized
90-Day Vol
129.7%
Annualized
Trend (90d)
+36.9%
Annualized drift
90d Mean
C$1.08
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.99 | C$0.65 – C$1.51 |
| 60 trading days | C$1.04 | C$0.57 – C$1.88 |
| 90 trading days | C$1.08 | C$0.52 – C$2.24 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About ZEN Graphene Solutions Ltd
Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. It develops graphene-based coatings under the ZenGUARD brand; graphene-enhanced intumescent gel under the ZenFire brand; carbon-based copolymeric icephobic coating under the ZenICE brand, and graphene-enhanced anti-corrosion coating under the ZenArmor brand. In addition, the company owns a 100% interest in the Albany graphite project located in Northern Ontario, Canada. The company was formerly known as ZEN Graphene Solutions Ltd. and changed its name to Zentek Ltd. in October 2021. Zentek Ltd. was incorporated in 2008 and is headquartered in Guelph, Canada.
Financials
- Revenue (TTM)
- $166,048
- EBITDA
- $-10.15M
- Profit Margin
- 0.00%
- ROE (TTM)
- -79.57%
- EPS (Diluted)
- -0.09
- Book Value
- 0.09
Classification
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Group
- Health Care Equipment & Services
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Advertisement
Common Questions About ZEN
Market movers
Recent TSX-V movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| ICON | International Iconic Gold Exploration Corp | $0.01 | +200.00% |
| MCF | Pinedale Energy Limited | $0.01 | +50.00% |
| MTX | Metalex Ventures Ltd. | $0.01 | +50.00% |
| LITT | Roadman Investments Corp | $0.20 | +48.15% |
| RRR-UN | R&R Real Estate Investment Trust | $0.07 | +36.36% |
| VCT | Volt Carbon Technologies Inc | $0.07 | +36.36% |
| LEAP | Quantum Critical Metals Corp. | $0.10 | +35.71% |
| XXIX | XXIX Metal Corp. | $0.15 | +34.78% |
ZEN.V news timeline
3 articles covering ZEN.V, most recent first
Latest